Death, Sudden, Cardiac Clinical Trial
Official title:
Evaluating the Genetic Factors That May Lead to Sudden Cardiac Arrest (The GenSCA Study)
Sudden cardiac arrest (SCA) is a sudden, unexpected loss of heart function. It is a leading cause of death, and more than 400,000 people in the United States die each year as a result of SCA. This study will analyze genetic samples of people who have experienced SCA and people who have not experienced SCA to determine if there is a genetic basis for SCA.
SCA occurs when the heart suddenly and unexpectedly stops beating. When this happens, blood stops flowing to the brain and other vital organs. Ninety-five percent of people who experience SCA die from it, most within minutes. SCA is usually caused by abnormal heart rhythms, known as arrhythmias, which can be triggered by several factors, including coronary artery disease, physical stress, and structural changes in the heart. Certain genetic factors may also increase the likelihood of experiencing SCA. Study researchers will analyze genetic samples from people affected by SCA and people unaffected by SCA to identify and characterize genetic variations that are associated with an increased risk of SCA in European Americans and African Americans. This study will examine previously collected blood samples from people who have experienced SCA and were participants in the Cardiac Arrest Blood Study (CABS) and the Cardiovascular Health Study (CHS). These participants will not attend any study visits or be contacted by study researchers. People who experience SCA in the first 4 years of this study will have blood drawn from paramedics at the time of SCA. If these participants survive, they will be asked whether study researchers can review their medical records. Study researchers will also examine previously collected blood samples from participants who have not experienced SCA and were participants in CABS, CHS, and the Heart and Vascular Health Study. These participants will not attend any study visits or be contacted by study researchers. Study researchers will also enroll a new control group of people who have not experienced SCA. These participants will attend one study visit for blood collection and a medical record review. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03700125 -
Pre-hospital ECMO in Advanced Resuscitation in Patients With Refractory Cardiac Arrest. ( SUB30 )
|
N/A | |
Withdrawn |
NCT00593164 -
Clinical Study of the LRS ThermoSuitâ„¢ System in Post Arrest Patients With Intravenous Infusion of Magnesium Sulfate
|
Phase 2 | |
Active, not recruiting |
NCT02244853 -
Heart Rate and Cardiovascular Diseases Prognosis in People With Stable Coronary Artery Disease
|
N/A | |
Withdrawn |
NCT00573092 -
Analyzing Gene Regions That May Interact With the Effectiveness of High Blood Pressure Drugs
|
N/A | |
Completed |
NCT00376532 -
Extracellular Matrix Marker of Arrhythmia Risk (EMMA)
|
N/A | |
Completed |
NCT00241800 -
Medications and the Risk of Sudden Cardiac Death
|
N/A | |
Completed |
NCT00047411 -
Home Use of Automatic External Defibrillators to Treat Sudden Cardiac Arrest
|
Phase 3 | |
Completed |
NCT00399503 -
Assessment of Noninvasive Methods to Identify Patients at Risk of Serious Arrhythmias After a Heart Attack
|
N/A | |
Completed |
NCT00004560 -
Public Access Defibrillation (PAD) Community Trial
|
Phase 3 | |
Completed |
NCT00000531 -
Antiarrhythmics Versus Implantable Defibrillators (AVID)
|
Phase 3 | |
Completed |
NCT00000480 -
Multicenter Unsustained Tachycardia Trial (MUSTT)
|
Phase 3 | |
Completed |
NCT00005265 -
Natural History of Coronary Heart Disease
|
N/A | |
Completed |
NCT00000492 -
Beta-Blocker Heart Attack Trial (BHAT)
|
Phase 3 | |
Completed |
NCT01949025 -
Prevention of Serious Adverse Events in Acute Care Hospitals by Afferent Limb and Response Method Intervention - the ALARM Intervention Study.
|
N/A | |
Completed |
NCT01789554 -
The Use of Mobile Phones in Out of Hospital Cardiac Arrest to Increase Bystander CPR
|
N/A | |
Completed |
NCT00382928 -
Automatic External Defibrillation Monitoring in Cardiac Arrest
|
Phase 1 | |
Terminated |
NCT00189423 -
ResQ Trial: Impact of an ITD and Active Compression Decompression CPR on Survival From Out-of-Hospital Cardiac Arrest
|
N/A | |
Completed |
NCT04132466 -
ASSURE WCD Clinical Evaluation - Conversion Efficacy Study
|
N/A | |
Completed |
NCT00000609 -
Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
|
Phase 3 | |
Completed |
NCT03065647 -
ECPR for Refractory Out-Of-Hospital Cardiac Arrest
|
N/A |